EP08.01-020 Phase 2 Platform Trial of Anti-TIGIT GSK'859A/EOS-448 + Anti-PD-1 Dostarlimab in Non-small Cell Lung Cancer (NSCLC).

Details

Language :

English

ISSN :

15560864

Volume :

17

Issue :

9

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

159037838

Full Text :

https://doi.org/10.1016/j.jtho.2022.07.592